Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Sanofi-Aventis Seeks China Partnerships, Not a Research Center

publication date: Apr 4, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Unlike its big pharma peers, Sanofi-Aventis will not build a research center in China. Instead, the company will seek to establish half a dozen research partnerships with China universities and state-sponsored research institutions. Potential targets mentioned for the research were cancer and rheumatoid arthritis. Dr. Marc Cuzel, head of R&D for Sanofi-Aventis, said that the advantage of working with existing institutions is the innovation that is already there. More details...

Stock Symbol: (NYSE: SNY)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...